Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug metabolism in extrahepatic diseases.

× No keyword cloud information.

7 in total

1. Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.

Authors: Agneta Wennerholm; Anna Nordmark; Maria Pihlsgård; Margarita Mahindi; Leif Bertilsson; Lars L Gustafsson
Journal: Eur J Clin Pharmacol Date: 2006-06-17 Impact factor: 2.953

Review 2. Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Authors: V Ozdemir; J Fourie; U Busto; C A Naranjo
Journal: Clin Pharmacokinet Date: 1996-11 Impact factor: 6.447

Review 3. Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

Authors: L L von Moltke; D J Greenblatt; J Schmider; J S Harmatz; R I Shader
Journal: Clin Pharmacokinet Date: 1995 Impact factor: 6.447

4. Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol.

Authors: P A Soons; C Grib; D D Breimer; W Kirch
Journal: Clin Pharmacokinet Date: 1992-09 Impact factor: 6.447

Drug metabolism in extrahepatic diseases.

1. Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.

Review 2. Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Review 3. Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

4. Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol.

Review 5. The effect of respiratory disorders on clinical pharmacokinetic variables.

6. Modification of inflammatory processes by phenobarbital in rats.

Review 7. Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.